tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Alex Thompson, 29 are a BUY (65.91%), 15 are a HOLD (34.09%).
Analyst Alex Thompson, currently employed at STIFEL, carries an average stock price target met ratio of 54.76% that have a potential upside of 50.55% achieved within 125 days.
Alex Thompson’s has documented 88 price targets and ratings displayed on 12 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MORF, Morphic at 22-Jul-2024.
Analyst best performing recommendations are on ACRS (ACLARIS THERAPEUTICS).
The best stock recommendation documented was for ACRS (ACLARIS THERAPEUTICS) at 12/18/2023. The price target of $1 was fulfilled within 1 day with a profit of $0.06 (6.38%) receiving and performance score of 63.83.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$48
$0.45 (0.95%)
$48
1 years 3 months 11 days ago
(09-Aug-2023)
1/8 (12.5%)
$0.45 (0.95%)
85
Hold
$56
1 years 4 months 25 days ago
(26-Jun-2023)
0/1 (0%)
$27.35 (95.46%)
Hold
$48
$0.45 (0.95%)
$68
1 years 5 months ago
(20-Jun-2023)
1/3 (33.33%)
$1.56 (3.36%)
27
Hold
$48
$0.45 (0.95%)
$38
1 years 5 months ago
(20-Jun-2023)
1/2 (50%)
$1.56 (3.36%)
27
Hold
$48
$0.45 (0.95%)
$71
1 years 5 months ago
(20-Jun-2023)
0/2 (0%)
$1.56 (3.36%)
Which stock is Alex Thompson is most bullish on?
Which stock is Alex Thompson is most reserved on?
What Year was the first public recommendation made by Alex Thompson?
